Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy CTi Biopharma stock
Learn how to easily invest in CTi Biopharma stock.
CTi Biopharma Corp is a biotechnology business based in the US. CTi Biopharma shares (CTIC) are listed on the NASDAQ and all prices are listed in US Dollars. CTi Biopharma employs 121 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in CTi Biopharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CTIC – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
CTi Biopharma stock price (NASDAQ: CTIC)Use our graph to track the performance of CTIC stocks over time.
CTi Biopharma shares at a glance
|Latest market close||$6.08|
|52-week range||$1.43 - $6.52|
|50-day moving average||$5.26|
|200-day moving average||$3.49|
|Wall St. target price||$9.58|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.23|
Buy CTi Biopharma shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy CTi Biopharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
CTi Biopharma price performance over time
|1 week (2022-06-28)||9.75%|
|1 month (2022-06-03)||5.74%|
|3 months (2022-04-05)||28.00%|
|6 months (2022-01-05)||162.07%|
|1 year (2021-07-02)||133.85%|
|2 years (2020-07-02)||415.25%|
|3 years (2019-07-05)||646.56%|
|5 years (2017-07-05)||80.42%|
CTi Biopharma financials
|Revenue TTM||$2.3 million|
|Gross profit TTM||$3.3 million|
|Return on assets TTM||-81.33%|
|Return on equity TTM||-447.11%|
|Market capitalisation||$662.5 million|
TTM: trailing 12 months
CTi Biopharma share dividends
We're not expecting CTi Biopharma to pay a dividend over the next 12 months.
Have CTi Biopharma's shares ever split?
CTi Biopharma's shares were split on a 1:10 basis on 2 January 2017. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CTi Biopharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for CTi Biopharma shares which in turn could have impacted CTi Biopharma's share price.
CTi Biopharma share price volatility
Over the last 12 months, CTi Biopharma's shares have ranged in value from as little as $1.43 up to $6.52. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CTi Biopharma's is 0.9837. This would suggest that CTi Biopharma's shares are less volatile than average (for this exchange).
CTi Biopharma overview
CTI BioPharma Corp. , a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd. ; S*BIO Pte Ltd. ; and Baxalta. The company was formerly known as Cell Therapeutics, Inc.
CTi Biopharma in the news
CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CTI BioPharma Presents Pivotal Data from Pacritinib Program at the European Hematology Association (EHA) 2022 Congress
Frequently asked questionsWhat percentage of CTi Biopharma is owned by insiders or institutions?
Currently 0.209% of CTi Biopharma shares are held by insiders and 62.611% by institutions. How many people work for CTi Biopharma?
Latest data suggests 121 work at CTi Biopharma. When does the fiscal year end for CTi Biopharma?
CTi Biopharma's fiscal year ends in December. Where is CTi Biopharma based?
CTi Biopharma's address is: 3101 Western Avenue, Seattle, WA, United States, 98121 What is CTi Biopharma's ISIN number?
CTi Biopharma's international securities identification number is: US12648L6011 What is CTi Biopharma's CUSIP number?
CTi Biopharma's Committee on Uniform Securities Identification Procedures number is: 12648L106
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert